Natalia Szczepańska

Natalia Szczepańska

Auto-generated profile, based on publicly available information

Natalia Szczepańska

Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2026 in Translational Lung Cancer Research
Verified
Journal Article
Open access
PDF file
JNJulia Niedzielska
Julia Niedzielska
NSNatalia Szczepańska
Natalia Szczepańska
ACAleksandra Ciarka
Aleksandra Ciarka
RPRafał Pęksa
Rafał Pęksa
ŁSŁukasz Szylberg
Łukasz Szylberg
TMTomasz Marjanski
Tomasz Marjanski
Background: Perioperative therapies have altered curative-intent treatment for resectable non-small cell lung cancer (NSCLC). Nonetheless, radical resection (R0) still remains one of the most vital determinants of the final clinical outcome. This study evaluates the definition of radical resection across perioperative NSCLC trials in the context of the National Comprehensive Cancer Network (NCCN) and International Association for the Study of Lung Cancer (IASLC) guidelines. Methods: A scoping review in accordance with PRISMA-ScR 2018 guidelines was conducted to identify suitable clinical trial protocols. PubMed and ClinicalTrials.gov were searched for trials published between 2020 and 2025, focusing on studies with full protocols in English that included surgical treatment of NSCLC. Surgical radicality and lymphadenectomy definitions provided in the protocols were extracted and evaluated for adherence to NCCN and IASLC guidelines. Each component was assigned a value of ‘1’ if the criterion was met and ‘0’ if it was not. These binary scores were subsequently used to assess the overall compliance with the guidelines. Results: Out of 563 records initially identified, 47 were ultimately included. Only 15% of studies fully met the radical resection criteria according to both the NCCN and IASLC guidelines. As for lymphadenectomy, 30% of studies adhered to the NCCN guidelines, while 15% followed the IASLC guidelines. Conclusions: These findings highlight the persistent lack of a clear and uniform definition of radical resection in NSCLC amongst trial protocols. Such heterogeneity pose difficulty in interpretability and comparability of clinical data. It is of utmost importance to reinforce a trend toward standardization, for the sake of both patients and physicians.

15 October 2026 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
TMTomasz Marjanski
Tomasz Marjanski
NSNatalia Szczepańska
Natalia Szczepańska
JNJulia Niedzielska
Julia Niedzielska
ACAleksandra Ciarka
Aleksandra Ciarka
RPRafał Pęksa
Rafał Pęksa
EMEwa Milnerowicz-Nabzdyk
Ewa Milnerowicz-Nabzdyk
Thoracic endometriosis syndrome (TES) is the most common extrapelvic manifestation of endometriosis, yet its classification, diagnosis, and treatment remain debated. Thoracic endometriosis syndrome has recently been proposed to be categorized into 3 types: pleural, bronchopulmonary, and diaphragmatic. Our study aims to propose a 3-step approach - computed tomography (CT) imaging, careful intraoperative assessment, and targeted pathology - to enhance the diagnostic process and optimize the management of TES-related pneumothorax. We retrospectively analyzed 3 cases of recurrent right-sided catamenial pneumothorax in female patients with a history of pelvic endometriosis, managed surgically at the Department of Thoracic Surgery, Medical University of Gdansk, between 2021 and 2024. All included patients underwent video-assisted thoracoscopic surgery (VATS), with comprehensive preoperative CT imaging, intraoperative lesion mapping, and postoperative histopathological examination, improving diagnostic accuracy in TES, with a possible impact on therapeutic results. Chest CT is essential for detecting bullous lesions, aiding in intraoperative identification and surgical treatment. Immunohistochemistry (IHC), assessing estrogen receptor (ER) and CD10 for stromal identification, improves pathological accuracy. This study underlines the diagnostic value of integrating imaging, intraoperative assessment, and targeted histopathology, as well as clear communication between surgeons, radiologists, and pathologists to ensure accurate diagnosis and an improved therapeutic process for patients in clinical practice.